AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 798269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31940376 — intervention group
Group type: EXPERIMENTAL
Intervention: Long decision aid (DA)
Number of subjects: 3000
Study 31940376 — intervention group
Group type: COMPARATOR
Intervention: Short decision aid (DA)
Number of subjects: 3000
Study 31525112 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated metrics for speech intelligibility assessment
Number of subjects: 73
Study 27859251 — intervention group
Group type: EXPERIMENTAL
Intervention: Paediatric fixed-dose combination (FDC) zidovudine/lamivudine/nevirapine (60/30/50 mg) tablet
Number of subjects: 24
Study 27859251 — intervention group
Group type: COMPARATOR
Intervention: Combined mixture of single-entity innovator products (reference product)
Number of subjects: 24
Study 26075487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 3-6 mg/d
Number of subjects: 446
Study 26075487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 6-9 mg/d
Number of subjects: 446
Study 26075487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 446
Study 23548123 — intervention group
Group type: EXPERIMENTAL
Intervention: Zishentongluo (ZSTL)
Number of subjects: 45
Study 23548123 — intervention group
Group type: COMPARATOR
Intervention: Benazepril
Number of subjects: 45
Study 21742106 — intervention group
Group type: EXPERIMENTAL
Intervention: TFG 0/1 prior to pPCI
Number of subjects: 8337
Study 21742106 — intervention group
Group type: EXPERIMENTAL
Intervention: TFG 2 prior to pPCI
Number of subjects: 8337
Study 21742106 — intervention group
Group type: EXPERIMENTAL
Intervention: TFG 3 prior to pPCI
Number of subjects: 8337
Study 19627913 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (strength training and aerobic components), 5 days per week, with gradually increased intensity and duration.
Number of subjects: 0
Study 19627913 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (strength training and aerobic components)
Number of subjects: 0
Study 19627913 — intervention group
Group type: COMPARATOR
Intervention: No exercise intervention (control group)
Number of subjects: 0
Study 16704693 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpupillary thermotherapy (TTT) using an 810-nm Oculight diode laser with a fixed spot size covering the whole lesion.
Number of subjects: 25
Study 16704693 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group) with power set at zero during the same procedure.
Number of subjects: 25
Study 15605617 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg/day for 12 weeks
Number of subjects: 20
Study 15605617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15530734 — intervention group
Group type: EXPERIMENTAL
Intervention: VR smoking cues
Number of subjects: 13
Study 15530734 — intervention group
Group type: COMPARATOR
Intervention: VR neutral cues
Number of subjects: 13
Study 11036827 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil derived (n‐3) fatty acid supplementation (3‐6 capsules/day, 40 mg/kg body weight)
Number of subjects: 50
Study 11036827 — intervention group
Group type: COMPARATOR
Intervention: Olive/corn oil capsule supplement (control)
Number of subjects: 50
Study 11036827 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 50
Study 8847860 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (100 mg once daily for 1 week)
Number of subjects: 40
Study 8847860 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once daily for 1 week)
Number of subjects: 40
Study 1543845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative TEE
Number of subjects: 57
Study 1543845 — intervention group
Group type: COMPARATOR
Intervention: Control (no TEE)
Number of subjects: 57
Study 3519142 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lung heparin
Number of subjects: 43
Study 3519142 — intervention group
Group type: COMPARATOR
Intervention: Porcine intestinal mucosa heparin
Number of subjects: 43
Study 3360858 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand A
Number of subjects: 6
Study 3360858 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand C
Number of subjects: 6
Study 3360858 — intervention group
Group type: COMPARATOR
Intervention: Brands F and B
Number of subjects: 6
Study 31933259 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-resection of recurrent glioblastoma multiforme
Number of subjects: 39
Study 31933259 — intervention group
Group type: COMPARATOR
Intervention: No re-resection (control group)
Number of subjects: 39
Study 30099647 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational lyric analysis
Number of subjects: 92
Study 30099647 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational songwriting
Number of subjects: 92
Study 30099647 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 92
Study 27466718 — intervention group
Group type: EXPERIMENTAL
Intervention: Isunakinra (5 mg/mL)
Number of subjects: 74
Study 27466718 — intervention group
Group type: EXPERIMENTAL
Intervention: Isunakinra (20 mg/mL)
Number of subjects: 74
Study 27466718 — intervention group
Group type: EXPERIMENTAL
Intervention: Isunakinra (5 mg/mL) and (20 mg/mL)
Number of subjects: 74
Study 27466718 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 74
Study 26343102 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered exercises based on Tuina techniques
Number of subjects: 69
Study 26343102 — intervention group
Group type: COMPARATOR
Intervention: Control group (Tuina exercises executed in points away from commonly-used acupuncture points)
Number of subjects: 69
Study 23833362 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical moxifloxacin alone (Group-1): One drop 6 times/day for 3 days before surgery and one drop 4 times on the day of surgery
Number of subjects: 50
Study 23833362 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical moxifloxacin with flurbiprofen (Group-2): One drop 6 times/day for 3 days before surgery and one drop 4 times on the day of surgery, plus flurbiprofen one drop 4 times/day for 3 days before and on the day of surgery
Number of subjects: 50
Study 21912022 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclo 10 mg/kg monthly for six months then every two months for 12 months (Group I)
Number of subjects: 117
Study 21912022 — intervention group
Group type: COMPARATOR
Intervention: Cyclo 5 mg/kg monthly for six months then every two months for 36 months (Group II)
Number of subjects: 117
Study 21912022 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclo 10 mg/kg (Group I)
Number of subjects: 117
Study 21912022 — intervention group
Group type: COMPARATOR
Intervention: Cyclo 5 mg/kg (Group II)
Number of subjects: 117
Study 19167276 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg (E)-entacapone tablet formulation
Number of subjects: 36
Study 17140457 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (YG, n = 146)
Number of subjects: 291
Study 17140457 — intervention group
Group type: COMPARATOR
Intervention: Wait list control (WL, n = 145)
Number of subjects: 291
Study 16095445 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with remifentanil (1 microg kg‐1 remifentanil + 0.5 mg kg‐1 propofol)
Number of subjects: 24
Study 16095445 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with alfentanil (10 microg kg‐1 alfentanil + 0.5 mg kg‐1 propofol)
Number of subjects: 24
Study 16095445 — intervention group
Group type: COMPARATOR
Intervention: Propofol (0.75 mg kg‐1)
Number of subjects: 24
Study 16095445 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with alfentanil and Propofol with remifentanil
Number of subjects: 24
Study 11549477 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubeless PCN
Number of subjects: 30
Study 11549477 — intervention group
Group type: COMPARATOR
Intervention: Standard PCN
Number of subjects: 30
Study 11549477 — intervention group
Group type: COMPARATOR
Intervention: Mini-PCN
Number of subjects: 30
Study 9768926 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade mild hypothermic blood cardioplegia
Number of subjects: 20
Study 9768926 — intervention group
Group type: COMPARATOR
Intervention: Retrograde mild hypothermic blood cardioplegia
Number of subjects: 20
Study 7810806 — intervention group
Group type: EXPERIMENTAL
Intervention: Total IgG antibodies
Number of subjects: 131
Study 7810806 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG4 antibodies
Number of subjects: 131
Study 7810806 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG1 antibodies
Number of subjects: 131
Study 7810806 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG2 and IgG3 antibodies
Number of subjects: 131
Study 3387717 — intervention group
Group type: EXPERIMENTAL
Intervention: Random walk model applied to treatment groups
Number of subjects: 0
Study 3387717 — intervention group
Group type: COMPARATOR
Intervention: Standard analysis (difference between initial and final scores)
Number of subjects: 0
Study 28215966 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 50
Study 28215966 — intervention group
Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB)
Number of subjects: 50
Study 24592875 — intervention group
Group type: EXPERIMENTAL
Intervention: Ostracism condition (Cyberball manipulation)
Number of subjects: 0
Study 24592875 — intervention group
Group type: COMPARATOR
Intervention: Inclusion condition (Cyberball manipulation)
Number of subjects: 0
Study 24592875 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispositional self-esteem
Number of subjects: 0
Study 23993139 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum ssp infantis (Binf)
Number of subjects: 21
Study 23993139 — intervention group
Group type: COMPARATOR
Intervention: Bifidobacterium animalis ssp lactis (Blac)
Number of subjects: 21
Study 22101745 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (PPX) 0.25-0.75 mg
Number of subjects: 39
Study 22101745 — intervention group
Group type: COMPARATOR
Intervention: Dual-release levodopa/benserazide (L/B) 125-375 mg
Number of subjects: 39
Study 22101745 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (PPX)
Number of subjects: 39
Study 22101745 — intervention group
Group type: COMPARATOR
Intervention: Dual-release levodopa/benserazide (L/B)
Number of subjects: 39
Study 19440101 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents of adult children with bipolar disorder
Number of subjects: 145
Study 19440101 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents of adult children with bipolar disorder with preexisting mental illness
Number of subjects: 145
Study 19440101 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (parents whose children did not have disabilities)
Number of subjects: 145
Study 16552520 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical (MIS) approach via subvastus; 40 TKAs implanted.
Number of subjects: 80
Study 16552520 — intervention group
Group type: COMPARATOR
Intervention: Standard approach using OrthoPilot navigation; 40 TKAs implanted.
Number of subjects: 80
Study 15351164 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention strategy (angiography followed by revascularization)
Number of subjects: 1810
Study 15351164 — intervention group
Group type: COMPARATOR
Intervention: Conservative care (ischaemia or symptom driven angiography)
Number of subjects: 1810
Study 11318055 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with slow speeds
Number of subjects: 0
Study 11318055 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with fast speeds
Number of subjects: 0
Study 11318055 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of ball speed and size
Number of subjects: 0
Study 11318055 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance across speed ranges
Number of subjects: 0
Study 9456421 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network computation
Number of subjects: 95
Study 9456421 — intervention group
Group type: COMPARATOR
Intervention: Holladay personalized calculation
Number of subjects: 95
Study 7943709 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge spinal needle
Number of subjects: 300
Study 7943709 — intervention group
Group type: EXPERIMENTAL
Intervention: 27-gauge spinal needle
Number of subjects: 300
Study 7943709 — intervention group
Group type: EXPERIMENTAL
Intervention: 29-gauge spinal needle
Number of subjects: 300
Study 7943709 — intervention group
Group type: COMPARATOR
Intervention: Larger bore needles (25- and 27-gauge)
Number of subjects: 300
Study 3651281 — intervention group
Group type: EXPERIMENTAL
Intervention: suxamethonium 1 mg kg‐1
Number of subjects: 0
Study 3651281 — intervention group
Group type: EXPERIMENTAL
Intervention: atracurium 0.4 mg kg‐1
Number of subjects: 0
Study 31226405 — intervention group
Group type: EXPERIMENTAL
Intervention: Piano training
Number of subjects: 360
Study 31226405 — intervention group
Group type: COMPARATOR
Intervention: Music listening instruction (active control)
Number of subjects: 360
Study 28189481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic pulmonary function tests (PFTs) including peak expiratory flow (PEF), forced vital capacity (FVC), forced expiratory volume in one second (FEV1)
Number of subjects: 64
Study 28189481 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum static airway pressures (MIP, MEP)
Number of subjects: 64
Study 28189481 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of MIP%p and MEP%p
Number of subjects: 64
Study 28189481 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-subject coefficients of variation (CV) for successive measures
Number of subjects: 64
Study 28189481 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition from Brooke score category 4 to category 5
Number of subjects: 64
Study 26380308 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-led group protocol
Number of subjects: 736
Study 26380308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer
Number of subjects: 736
Study 26380308 — intervention group
Group type: COMPARATOR
Intervention: Control group (135 active participants)
Number of subjects: 736
Study 23963471 — intervention group
Group type: EXPERIMENTAL
Intervention: High-rate rTMS (10 Hz, 600 pulses in 10 trains, delivered to the hot spot of the right abductor digiti minimi, 3 sessions on alternate days)
Number of subjects: 100
Study 23963471 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 100
Study 23963471 — intervention group
Group type: EXPERIMENTAL
Intervention: High-rate rTMS
Number of subjects: 100
Study 21385294 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based peer support with maternal-infant interaction teaching (12 weeks)
Number of subjects: 60
Study 21385294 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 19196814 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclometasone (200 microg day(‐1)) + Theophylline (400 mg day(‐1))
Number of subjects: 68
Study 19196814 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (400 mg day(‐1))
Number of subjects: 68
Study 19196814 — intervention group
Group type: COMPARATOR
Intervention: Inhaled beclometasone (200 microg day(‐1))
Number of subjects: 68
Study 17848668 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg daily)
Number of subjects: 9898
Study 17848668 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 9898
Study 17848668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9898
Study 15103566 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition solution containing arginine, nucleotides, and polyunsaturated fatty acids
Number of subjects: 30
Study 15103566 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric solution
Number of subjects: 30
Study 11339730 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous infusion using the bone injection gun (BIG)
Number of subjects: 13
Study 11339730 — intervention group
Group type: EXPERIMENTAL
Intervention: Saphenous vein cutdown
Number of subjects: 13
Study 9072603 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intercourse prophylaxis (group 1, 70 patients)
Number of subjects: 135
Study 9072603 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily prophylaxis (group 2, 65 patients)
Number of subjects: 135
Study 9072603 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intercourse prophylaxis (group 1)
Number of subjects: 135
Study 9072603 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily prophylaxis (group 2)
Number of subjects: 135
Study 7701881 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide cream (Microcid)
Number of subjects: 256
Study 7701881 — intervention group
Group type: COMPARATOR
Intervention: Fusidic acid cream/gel (Fucidin)
Number of subjects: 256
Study 7701881 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 256
Study 3427696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin 2 g IV every 8 hours
Number of subjects: 20
Study 3427696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime 2 g IV every 8 hours
Number of subjects: 20
Study 3427696 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam 2 g IV every 8 hours
Number of subjects: 20
Study 3427696 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam 2 g IV every 8 hours
Number of subjects: 20
Study 31398135 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-learning-based in-vehicle learning system
Number of subjects: 0
Study 31398135 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage deployment solution for PHEV power management applications
Number of subjects: 0
Study 31398135 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network (NN) for predicting battery state-of-charge (SoC)
Number of subjects: 0
Study 29540445 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 2.4 g per day
Number of subjects: 42
Study 29540445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 26883688 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine with topical vaginal estrogen
Number of subjects: 23
Study 26883688 — intervention group
Group type: COMPARATOR
Intervention: fesoterodine alone
Number of subjects: 23
Study 23855018 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful eating intervention (MB-EAT-D)
Number of subjects: 52
Study 23855018 — intervention group
Group type: COMPARATOR
Intervention: Diabetes self-management education (DSME) 'Smart Choices' (SC)
Number of subjects: 52
Study 23855018 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MB-EAT-D and SC
Number of subjects: 52
Study 22789840 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime napping
Number of subjects: 20
Study 22789840 — intervention group
Group type: COMPARATOR
Intervention: Controlled activity
Number of subjects: 20
Study 20044764 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐J stenting (Group A)
Number of subjects: 184
Study 20044764 — intervention group
Group type: COMPARATOR
Intervention: No D‐J stenting (Group B)
Number of subjects: 184
Study 17764471 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic prompt in dispensing software
Number of subjects: 150
Study 17764471 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electronic prompt)
Number of subjects: 150
Study 16092048 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects without complications (n = 65)
Number of subjects: 157
Study 16092048 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic subjects (n = 38)
Number of subjects: 157
Study 16092048 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects with retinopathy (n = 29)
Number of subjects: 157
Study 16092048 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects with both retinopathy and nephropathy (n = 25)
Number of subjects: 157
Study 12420256 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.25 mg/kg
Number of subjects: 90
Study 12420256 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg
Number of subjects: 90
Study 12420256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 10328274 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal-scalp temperature difference greater than 4 degrees C; Mean = 6.7, Range = 6.0-7.4; At the time of clinical brain death
Number of subjects: 12
Study 10328274 — intervention group
Group type: COMPARATOR
Intervention: No intervention; Control group of survivors
Number of subjects: 12
Study 10328274 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal-abdomen and rectal-mastoid temperature differences; No specific values reported
Number of subjects: 12
Study 8617696 — intervention group
Group type: EXPERIMENTAL
Intervention: SMD subjects with rocking or thumb sucking
Number of subjects: 12
Study 8617696 — intervention group
Group type: EXPERIMENTAL
Intervention: SMD subjects
Number of subjects: 12
Study 1566985 — intervention group
Group type: EXPERIMENTAL
Intervention: Through-the-Tuohy (needle within needle) approach
Number of subjects: 100
Study 1566985 — intervention group
Group type: COMPARATOR
Intervention: Sequential siting in separate spaces
Number of subjects: 100
Study 4051157 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dantrolene 1.5 mg/kg administered orally 4 hours pre-operatively
Number of subjects: 40
Study 4051157 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dantrolene)
Number of subjects: 40
Study 30874324 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed and bedside chair pressure sensors linked to radio pagers
Number of subjects: 0
Study 30874324 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 29045283 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART initiation
Number of subjects: 1000
Study 29045283 — intervention group
Group type: COMPARATOR
Intervention: Delayed ART initiation
Number of subjects: 1000
Study 24293583 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 0
Study 24293583 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA) + Methotrexate (MTX)
Number of subjects: 0
Study 22776567 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized acupuncture therapy
Number of subjects: 945
Study 22776567 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 945
Study 22776567 — intervention group
Group type: COMPARATOR
Intervention: Shallow acupuncture
Number of subjects: 945